Navigation Links
Relief from Migraine

Participants in a migraine medication study who cheated and took the drug earlier than suggested may have done migraine sufferers everywhere a big favor.//

A new study shows the medication works best when taken at the first sign of pain, rather than waiting until pain is moderate to severe, as was the requirement of the original study.

Previous research on the use of drugs known as serotonin agonists for the treatment of migraine have required patients to take the drugs only when their pain reached moderate to severe levels. However, patients in one study on the drug sumatriptan violated this rule, taking the medication as soon as they felt a migraine coming on. Researchers analyzed their results separately, and noted treatment of mild pain may be a better strategy.

Investigators conducted two identical studies to see if using sumatriptan for mild pain had the desired effects. The first study involved 354 patients and the second involved 337 patients. Patients were randomized to receive either the active drug or a placebo. Results showed significantly better pain control among those taking the active drug in either 50 milligram or 100 milligram doses. Fifty percent of those taking the lower dose and 57 percent taking the higher dose reported they were completely free from pain two hours later, compared to 29 percent of those taking the placebo. At four hours, 61 percent and 68 percent, respectively, were free from pain, compared to 30 percent for the placebo. Similar numbers were found when the researchers measured freedom from both pain and other migraine symptoms at two and four hours.
'"/>




Page: 1

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Relief from common back pain
3. Relief to pregnant women using fertility drugs
4. Relief of pain for suffering patients
5. Relief from cancer pain with anticonvulsants
6. Pain Relief For Osteoarthritis Patients
7. Relief From Migraines
8. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Relief For Women Suffering From Fibromyalgia
11. Lemons Could Give Relief For Patients Suffering From Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... ... Levels of a protein in the blood associated with heart disease are ... journal Radiology. , Heart disease and brain disease exact a major burden on society, ... Damage to both organs often occurs at a subclinical stage, or before signs and ...
(Date:12/7/2016)... ... December 07, 2016 , ... They are musicians and librarians, fashion ... brothers and fathers, from New England and around the nation. What do they have ... brought together in a beautiful and compelling new photographic exhibit debuting Friday, December 9 ...
(Date:12/7/2016)... ... ... came time to blow out his candles on his 14th birthday, Estefano Reano had only ... team at Joe DiMaggio Children’s Hospital surprised his family with a phone call that made ... , “He was playing at home, when we got the phone call telling us there ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... connectors, is now promoting to the US market its advanced highly customizable contact ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... financial consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, ... a basketball coach who needs treatment for a brain tumor. , Jason Bauer ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Varian Medical Systems (NYSE: ... previously announced plans to separate its Imaging Components business.  ... tax-free distribution to Varian stockholders of common stock in ... will hold the Imaging Components business.  As part of ... by the end of January 2017, Varian will receive ...
(Date:12/7/2016)... PUNE, India , December 7, 2016 According ... Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type ... by MarketsandMarkets, The CDSS Market is expected to reach USD 1,519.2 Million ... 12.2%. Continue Reading ... ...
(Date:12/7/2016)... RIDGEFIELD, Conn. , Dec. 7, 2016 /PRNewswire/ ... Phase II trial in patients with unresectable malignant ... progression-free survival (PFS). The data, presented at the ... Cancer in Vienna , showed ... compared to placebo plus pemetrexed/cisplatin, with a significantly ...
Breaking Medicine Technology: